- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Pharmicell (005690)
Pharmicell stock price live, this page displays KS 005690 stock exchange data. View the 005690 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Pharmicell real time stock price chart below.
What Is the Pharmicell Stock Price Today?
The Pharmicell stock price today is 16,740.
What Is the Stock Symbol for Pharmicell?
The stock symbol for Pharmicell is "005690."
What Stock Exchange Does Pharmicell Trade On?
Pharmicell is listed and trades on the Seoul stock exchange.
Is Pharmicell a Good Stock to Buy?
Determining whether Pharmicell—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 005690 quote. (ISIN: KR7005690003)
What Is the Pharmicell Stock Price Today?
The Pharmicell stock price today is 16,740.
What Is the Stock Symbol for Pharmicell?
The stock symbol for Pharmicell is "005690."
What Stock Exchange Does Pharmicell Trade On?
Pharmicell is listed and trades on the Seoul stock exchange.
Is Pharmicell a Good Stock to Buy?
Determining whether Pharmicell—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 005690 quote. (ISIN: KR7005690003)
Seoul
Currency in KRW
16,740
-300(-1.76%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16,360
17,210
52 wk Range
8,860
20,800
005690 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16,36017,210
52 wk Range
8,86020,800
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.30%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.30%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
005690 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
24,000
Upside
+43.37%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Pharmicell Co., Ltd., a biopharmaceutical company, develops and sells autologous drugs in South Korea and internationally. The company operates in Biopharmaceutical Business and Biochemical Business divisions. It offers Cellgram_AMI that is manufactured using autologous bone marrow-derived mesenchymal stem cell to improve the ejection fraction in patients with acute myocardial infarction reperfused by coronary angioplasty. The company’s products under development include Cellgram_LC to treat hepatic insufficiency; Cellgram_ED for treating impotence; and Hearticellgram_AMI, a cardiac disease drug. It develops and produces intermediates of raw material medicines, such as nucleosides and mPEGs; and low dielectric constant material, eco-friendly flame retardant, polyol synthesis catalyst, PET catalyst, etc. In addition, the company provides Half-Serum DMEM, a cell culture medium; and PharmiSTEM culture medium for mesenchymal stem cells, as well as clinical development and commercialization services for new drugs. Further, it operates stem cell bank under Twelve brand name; and develops and sells stem cell culture media cosmetics. The company was formerly known as FcB2welve Co., Ltd and changed its name to Pharmicell Co., Ltd. in September 2011. Pharmicell Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea.
Compare 005690 to Peers and Sector
Metrics to compare | 005690 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship005690PeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −4.3x | −0.4x | |
PEG Ratio | 0.00 | −0.07 | 0.00 | |
Price/Book | 0.0x | 1.8x | 2.6x | |
Price / LTM Sales | 0.0x | 13.6x | 3.2x | |
Upside (Analyst Target) | 0.0% | 37.2% | 50.6% | |
Fair Value Upside | Unlock | 16.7% | 6.6% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 24,000
(+43.37% Upside)
Earnings
Latest Release
Mar 18, 2026
EPS / Forecast
262.00 / --
Revenue / Forecast
34.6B / --
People Also Watch
FAQ
What Is the Pharmicell (005690) Stock Price Today?
The Pharmicell stock price today is 16,740 KRW.
What Stock Exchange Does Pharmicell Trade On?
Pharmicell is listed and trades on the Seoul Stock Exchange.
What Is the Stock Symbol for Pharmicell?
The stock symbol for Pharmicell is "005690."
Does Pharmicell Pay Dividends? What’s The Current Dividend Yield?
The Pharmicell dividend yield is 0.3%.
What Is the Pharmicell Market Cap?
As of today, Pharmicell market cap is 1.02T KRW.
What Is Pharmicell's Earnings Per Share (TTM)?
The Pharmicell EPS (TTM) is -614.
When Is the Next Pharmicell Earnings Date?
Pharmicell will release its next earnings report on May 19, 2026.
From a Technical Analysis Perspective, Is 005690 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Pharmicell Stock Split?
Pharmicell has split 5 times.
What is the current trading status of Pharmicell (005690)?
As of Apr 10, 2026, Pharmicell (005690) is trading at a price of 16,740 KRW, with a previous close of 17,040 KRW. The stock has fluctuated within a day range of 16,360 KRW to 17,210 KRW, while its 52-week range spans from 8,860 KRW to 20,800 KRW.
What Is Pharmicell (005690) Price Target According to Analysts?
The average 12-month price target for Pharmicell is 24,000 KRW, with a high estimate of 24000 KRW and a low estimate of 24000 KRW. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +43.37% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.